Corrigendum to “The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care” [Contemp. Clin. Trials (Contemporary Clinical Trials (2016) (72–77) (S1551714416302452) (10.1016/j.cct.2016.10.005))

Stacy Cooper Bailey*, Michael K. Paasche-Orlow, William G. Adams, Samantha A. Brokenshire, Laura A. Hedlund, Ryan P. Hickson, Christine U. Oramasionwu, Amy L. Moore, Danielle M. McCarthy, Laura M. Curtis, Mary J. Kwasny, Michael S. Wolf

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum to “The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care” [Contemp. Clin. Trials (Contemporary Clinical Trials (2016) (72–77) (S1551714416302452) (10.1016/j.cct.2016.10.005))'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science